JHP PHARMACEUTICALS, LLC – Trademark Portfolio

Entity Type: 16

JHP PHARMACEUTICALS, LLC holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 11 filings in this category. The portfolio also extends into Class 40 (Treatment & Processing) across 2 Nice Classification classes. Currently, 9 trademarks are registered. Notable registered marks include KETALAR, PITOCIN, DANTRIUM, VASOSTRICT, and JHP PHARMACEUTICALS. The owner is based in Parsippany, NJ.

Building D - 3rd Floor

1 Upper Pond Road

Parsippany, NJ 07054

12 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

JHP PHARMACEUTICALS, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (11 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

40
Treatment & Processing (2 filings)

Treatment of materials

Frequently Asked Questions

How many trademarks does JHP PHARMACEUTICALS, LLC have?

JHP PHARMACEUTICALS, LLC has 12 U.S. trademarks filed with the USPTO. Of these, 9 registered, 2 abandoned, 1 cancelled.

What trademark classes does JHP PHARMACEUTICALS, LLC file in?

JHP PHARMACEUTICALS, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are JHP PHARMACEUTICALS, LLC's most well-known trademarks?

JHP PHARMACEUTICALS, LLC's registered trademark portfolio includes well-known marks such as KETALAR, PITOCIN, DANTRIUM, VASOSTRICT, and JHP PHARMACEUTICALS. These are among 9 currently registered trademarks in the portfolio.

What is JHP PHARMACEUTICALS, LLC's trademark registration success rate?

JHP PHARMACEUTICALS, LLC has a 75% trademark registration rate, with 9 out of 12 resolved applications resulting in successful registration. Currently, 0 applications are pending review.